JP2018533582A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018533582A5 JP2018533582A5 JP2018522126A JP2018522126A JP2018533582A5 JP 2018533582 A5 JP2018533582 A5 JP 2018533582A5 JP 2018522126 A JP2018522126 A JP 2018522126A JP 2018522126 A JP2018522126 A JP 2018522126A JP 2018533582 A5 JP2018533582 A5 JP 2018533582A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- use according
- pharmaceutically acceptable
- acceptable salt
- acid ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562248632P | 2015-10-30 | 2015-10-30 | |
| US62/248,632 | 2015-10-30 | ||
| US201662281964P | 2016-01-22 | 2016-01-22 | |
| US62/281,964 | 2016-01-22 | ||
| US201662323034P | 2016-04-15 | 2016-04-15 | |
| US62/323,034 | 2016-04-15 | ||
| PCT/US2016/059342 WO2017075363A1 (en) | 2015-10-30 | 2016-10-28 | Compositions and methods for inhibiting arginase activity |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021014795A Division JP7032583B2 (ja) | 2015-10-30 | 2021-02-02 | アルギナーゼ活性を阻害する組成物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018533582A JP2018533582A (ja) | 2018-11-15 |
| JP2018533582A5 true JP2018533582A5 (enExample) | 2020-03-19 |
| JP6833844B2 JP6833844B2 (ja) | 2021-02-24 |
Family
ID=58631120
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018522126A Active JP6833844B2 (ja) | 2015-10-30 | 2016-10-28 | アルギナーゼ活性を阻害する組成物及び方法 |
| JP2021014795A Expired - Fee Related JP7032583B2 (ja) | 2015-10-30 | 2021-02-02 | アルギナーゼ活性を阻害する組成物及び方法 |
| JP2022025334A Withdrawn JP2022071010A (ja) | 2015-10-30 | 2022-02-22 | アルギナーゼ活性を阻害する組成物及び方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021014795A Expired - Fee Related JP7032583B2 (ja) | 2015-10-30 | 2021-02-02 | アルギナーゼ活性を阻害する組成物及び方法 |
| JP2022025334A Withdrawn JP2022071010A (ja) | 2015-10-30 | 2022-02-22 | アルギナーゼ活性を阻害する組成物及び方法 |
Country Status (36)
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX348422B (es) | 2010-04-22 | 2017-06-12 | Mars Inc | Inhibidores de arginasa y sus aplicaciones terapeuticas. |
| DK2632927T3 (en) | 2010-10-26 | 2016-04-11 | Mars Inc | Boronates AS ARGINSASEINHIBITORER |
| US10065974B2 (en) | 2015-10-30 | 2018-09-04 | Calithera Biosciences, Inc. | Compositions and methods for inhibiting arginase activity |
| PL417066A1 (pl) | 2016-05-04 | 2017-11-06 | Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością | Inhibitory arginazy oraz ich zastosowania terapeutyczne |
| EP3538111B1 (en) | 2016-11-08 | 2022-01-19 | Calithera Biosciences, Inc. | Arginase inhibitor combination therapies |
| ES2970715T3 (es) * | 2016-12-22 | 2024-05-30 | Prec Pharmaceuticals Inc | Composiciones y métodos para inhibir la actividad de la arginasa |
| AU2018265873A1 (en) | 2017-05-12 | 2019-11-28 | Calithera Biosciences, Inc. | Method of preparing (3R,4S)-3-acetamido-4-allyl-N-(tert-butyl)pyrrolidine-3-carboxamide |
| CN111491937A (zh) * | 2017-12-22 | 2020-08-04 | 广东新契生物医药科技有限公司 | 作为精氨酸酶抑制剂的杂环化合物 |
| CR20200418A (es) | 2018-02-17 | 2020-10-27 | Astrazeneca Ab | Inhibidores de orginasa y sus mètodos de uso antecedentes |
| KR102656571B1 (ko) | 2018-03-05 | 2024-04-11 | 아르커스 바이오사이언시즈 인코포레이티드 | 아르기나아제 억제제 |
| US12215116B2 (en) | 2018-03-13 | 2025-02-04 | Merck Sharp & Dohme Llc | Arginase inhibitors and methods of use |
| PL3774843T3 (pl) | 2018-03-29 | 2022-11-14 | Molecure Sa | Dipeptydowe pochodne piperydyny |
| WO2019245890A1 (en) | 2018-06-20 | 2019-12-26 | Merck Sharp & Dohme Corp. | Arginase inhibitors and methods of use |
| WO2020102646A2 (en) | 2018-11-16 | 2020-05-22 | Arcus Biosciences, Inc. | Inhibitors of arg1 and/or arg2 |
| CN109364252B (zh) * | 2018-11-21 | 2021-09-28 | 南京大学 | 抑制ifn-i至arg1诱导通路在制备抗肿瘤药物组合物中的应用 |
| US12240867B2 (en) | 2018-12-18 | 2025-03-04 | Merck Sharp & Dohme Llc | Arginase inhibitors and methods of use |
| EP3917936A4 (en) * | 2019-02-06 | 2022-12-14 | Guangdong Newopp Biopharmaceuticals Co., Ltd. | ALKYBORONIC ACIDS AS ARGINASE INHIBITORS |
| AU2020265828A1 (en) * | 2019-05-02 | 2021-09-09 | Aclaris Therapeutics, Inc. | Substituted pyrrolopyridines as JAK inhibitors |
| AU2020319132B2 (en) * | 2019-07-23 | 2023-09-07 | Astrazeneca Ab | Arginase inhibitors and methods of use thereof |
| CN110615753A (zh) * | 2019-09-02 | 2019-12-27 | 南京新酶合医药科技有限公司 | 一种(3r,4s)-1-取代-4-乙基吡咯-3-羧酸的合成方法 |
| CN110759843A (zh) * | 2019-09-30 | 2020-02-07 | 东北师范大学 | 一种氟叠氮取代的四元杂环化合物的制备和应用 |
| CN110734456A (zh) * | 2019-11-06 | 2020-01-31 | 南京谷睿生物科技有限公司 | 一种化合物及其制备方法和医药上的应用 |
| CN118286450A (zh) | 2019-11-12 | 2024-07-05 | 纳米医疗有限公司 | 用于治疗癌症的含有ido拮抗剂前药的调配的和/或共同调配的脂质体组合物及其方法 |
| EP4087583A4 (en) * | 2020-01-07 | 2024-01-24 | Merck Sharp & Dohme LLC | Arginase inhibitors and methods of use |
| WO2021257857A1 (en) | 2020-06-19 | 2021-12-23 | Incyte Corporation | Naphthyridinone compounds as jak2 v617f inhibitors |
| WO2021257863A1 (en) | 2020-06-19 | 2021-12-23 | Incyte Corporation | Pyrrolotriazine compounds as jak2 v617f inhibitors |
| WO2022006457A1 (en) | 2020-07-02 | 2022-01-06 | Incyte Corporation | Tricyclic urea compounds as jak2 v617f inhibitors |
| US11767323B2 (en) | 2020-07-02 | 2023-09-26 | Incyte Corporation | Tricyclic pyridone compounds as JAK2 V617F inhibitors |
| WO2022016195A1 (en) | 2020-07-17 | 2022-01-20 | Incyte Corporation | Processes for the preparation of arginase inhibitors and their synthetic intermediates |
| WO2022046989A1 (en) | 2020-08-27 | 2022-03-03 | Incyte Corporation | Tricyclic urea compounds as jak2 v617f inhibitors |
| US11919908B2 (en) | 2020-12-21 | 2024-03-05 | Incyte Corporation | Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibitors |
| TW202228720A (zh) | 2020-12-22 | 2022-08-01 | 波蘭商昂科艾倫迪治療法股份公司 | 精胺酸酶抑制劑及其使用方法 |
| WO2022182839A1 (en) | 2021-02-25 | 2022-09-01 | Incyte Corporation | Spirocyclic lactams as jak2 v617f inhibitors |
| JP2025509672A (ja) | 2022-03-17 | 2025-04-11 | インサイト・コーポレイション | Ｊａｋ２ ｖ６１７ｆ阻害剤としての三環式尿素化合物 |
| US20240190876A1 (en) | 2022-10-21 | 2024-06-13 | Incyte Corporation | Tricyclic Urea Compounds As JAK2 V617F Inhibitors |
| CN121079299A (zh) | 2023-03-13 | 2025-12-05 | 因赛特公司 | 作为激酶抑制剂的双环脲 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4172896A (en) | 1978-06-05 | 1979-10-30 | Dainippon Pharmaceutical Co., Ltd. | Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same |
| GB9217295D0 (en) | 1992-08-14 | 1992-09-30 | Wellcome Found | Controlled released tablets |
| GB9315856D0 (en) | 1993-07-30 | 1993-09-15 | Wellcome Found | Stabilized pharmaceutical |
| US5541231A (en) | 1993-07-30 | 1996-07-30 | Glaxo Wellcome Inc. | Stabilized Pharmaceutical |
| US5358970A (en) | 1993-08-12 | 1994-10-25 | Burroughs Wellcome Co. | Pharmaceutical composition containing bupropion hydrochloride and a stabilizer |
| CN100408100C (zh) | 1997-07-29 | 2008-08-06 | 阿尔康实验室公司 | 含半乳甘露聚糖聚合物和硼酸盐的眼用组合物 |
| WO1999019295A1 (en) | 1997-10-10 | 1999-04-22 | Trustees Of The University Of Pennsylvania | Compositions and methods for inhibiting arginase activity |
| JP2002501892A (ja) | 1998-01-29 | 2002-01-22 | セプラコア インコーポレーテッド | 光学的に純粋な（−）−ビュープロピオンの薬学的使用 |
| US20040063666A1 (en) | 1998-10-09 | 2004-04-01 | David Christianson | Compositions for inhibiting arginase activity |
| US8889112B2 (en) | 1999-09-16 | 2014-11-18 | Ocularis Pharma, Llc | Ophthalmic formulations including selective alpha 1 antagonists |
| WO2002004465A1 (en) | 2000-07-06 | 2002-01-17 | Fal Diagnostics | Methods and kits for the detection of arginine compounds |
| CA2431080A1 (en) | 2003-06-02 | 2004-12-02 | Catherine Adele O'brien | Enhancement of anticancer immunity through inhibition of arginase |
| US6933289B2 (en) | 2003-07-01 | 2005-08-23 | Allergan, Inc. | Inhibition of irritating side effects associated with use of a topical ophthalmic medication |
| US8512717B2 (en) | 2003-08-07 | 2013-08-20 | Allergan, Inc. | Compositions for delivery of therapeutics into the eyes and methods for making and using same |
| US20050059744A1 (en) | 2003-09-12 | 2005-03-17 | Allergan, Inc. | Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions |
| US20090298912A1 (en) | 2005-07-01 | 2009-12-03 | The Johns Hopkins University | Arginase II: A Target treatment of aging heart and heart failure |
| US20100189544A1 (en) | 2007-07-12 | 2010-07-29 | Sanyo Denki Co., Ltd. | Counter-rotating axial-flow fan |
| KR20150115959A (ko) * | 2007-10-12 | 2015-10-14 | 레솔빅스 파마슈티칼즈, 인코퍼레이티드 | 안과 질환의 치료를 위한 옥실리핀 화합물 |
| MX2010012064A (es) * | 2008-05-05 | 2010-12-06 | Schering Corp | Uso secuencial de agentes quimioterapeuticos citotoxicos para el tratamiento de cancer. |
| JP2012515799A (ja) | 2009-01-26 | 2012-07-12 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | アルギナーゼ阻害剤および使用方法 |
| MX348422B (es) | 2010-04-22 | 2017-06-12 | Mars Inc | Inhibidores de arginasa y sus aplicaciones terapeuticas. |
| DK2632927T3 (en) * | 2010-10-26 | 2016-04-11 | Mars Inc | Boronates AS ARGINSASEINHIBITORER |
| US8894970B2 (en) | 2010-12-31 | 2014-11-25 | Corridor Pharmaceuticals, Inc. | Arginase inhibitors and methods of use thereof |
| CA2852685C (en) | 2011-10-19 | 2019-02-26 | Mars, Incorporated | Inhibitors of arginase and their therapeutic application |
| WO2013059587A1 (en) | 2011-10-20 | 2013-04-25 | Sirtris Pharmaceuticals, Inc. | Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators |
| CA2870526C (en) | 2012-04-18 | 2020-05-05 | Mars, Incorporated | Ring constrained analogs as arginase inhibitors |
| EA201590822A1 (ru) * | 2012-11-02 | 2016-01-29 | Фармасайкликс, Инк. | Адъювантная терапия ингибитором киназы семейства tec |
| JP6508785B2 (ja) | 2013-10-25 | 2019-05-08 | ファーマサイクリックス エルエルシー | ブルトンチロシンキナーゼ阻害剤および免疫療法を使用する処置 |
| CN105879030A (zh) | 2014-09-30 | 2016-08-24 | 复旦大学 | 治疗肿瘤的增效药物复合物及其制备方法 |
| WO2016153078A1 (en) | 2015-03-20 | 2016-09-29 | Opiyo Sammy Oyoo | Use of suramin and arginase inhibitors in malignant neoplasia |
| US10143699B2 (en) * | 2015-06-23 | 2018-12-04 | Calithera Biosciences, Inc. | Compositions and methods for inhibiting arginase activity |
| US10065974B2 (en) | 2015-10-30 | 2018-09-04 | Calithera Biosciences, Inc. | Compositions and methods for inhibiting arginase activity |
| PL417066A1 (pl) | 2016-05-04 | 2017-11-06 | Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością | Inhibitory arginazy oraz ich zastosowania terapeutyczne |
-
2016
- 2016-10-28 US US15/337,041 patent/US10065974B2/en active Active
- 2016-10-28 TW TW110129153A patent/TWI775556B/zh not_active IP Right Cessation
- 2016-10-28 SI SI201630892T patent/SI3368541T1/sl unknown
- 2016-10-28 ES ES20165627T patent/ES2910928T3/es active Active
- 2016-10-28 LT LTEP16860883.4T patent/LT3368541T/lt unknown
- 2016-10-28 CA CA3003271A patent/CA3003271A1/en active Pending
- 2016-10-28 RS RS20200836A patent/RS60695B1/sr unknown
- 2016-10-28 MA MA050636A patent/MA50636A/fr unknown
- 2016-10-28 PH PH1/2022/551082A patent/PH12022551082A1/en unknown
- 2016-10-28 PL PL16860883T patent/PL3368541T3/pl unknown
- 2016-10-28 ES ES22150809T patent/ES2991555T3/es active Active
- 2016-10-28 CN CN202110097870.5A patent/CN113150015A/zh active Pending
- 2016-10-28 EP EP20165627.9A patent/EP3693375B1/en active Active
- 2016-10-28 MD MDE20180870T patent/MD3368541T2/ro unknown
- 2016-10-28 SG SG10201911402YA patent/SG10201911402YA/en unknown
- 2016-10-28 CN CN202110099500.5A patent/CN113201002A/zh active Pending
- 2016-10-28 ES ES16860883T patent/ES2808988T3/es active Active
- 2016-10-28 UA UAA201805902A patent/UA125289C2/uk unknown
- 2016-10-28 EP EP22150809.6A patent/EP4011887B1/en active Active
- 2016-10-28 AU AU2016343656A patent/AU2016343656B2/en not_active Ceased
- 2016-10-28 EA EA201891057A patent/EA038276B1/ru unknown
- 2016-10-28 CN CN201680063897.XA patent/CN108271371B/zh active Active
- 2016-10-28 CR CR20180282A patent/CR20180282A/es unknown
- 2016-10-28 SM SM20200469T patent/SMT202000469T1/it unknown
- 2016-10-28 NZ NZ742742A patent/NZ742742A/en not_active IP Right Cessation
- 2016-10-28 PT PT168608834T patent/PT3368541T/pt unknown
- 2016-10-28 TW TW109135297A patent/TWI734630B/zh not_active IP Right Cessation
- 2016-10-28 BR BR122020022280-8A patent/BR122020022280B1/pt active IP Right Grant
- 2016-10-28 SG SG10201911406TA patent/SG10201911406TA/en unknown
- 2016-10-28 SG SG10202003966RA patent/SG10202003966RA/en unknown
- 2016-10-28 EP EP16860883.4A patent/EP3368541B1/en active Active
- 2016-10-28 BR BR112018008746-7A patent/BR112018008746B1/pt not_active IP Right Cessation
- 2016-10-28 DK DK16860883.4T patent/DK3368541T3/da active
- 2016-10-28 WO PCT/US2016/059342 patent/WO2017075363A1/en not_active Ceased
- 2016-10-28 CR CR20210389A patent/CR20210389A/es unknown
- 2016-10-28 SG SG11201802961PA patent/SG11201802961PA/en unknown
- 2016-10-28 TW TW105135189A patent/TWI710565B/zh not_active IP Right Cessation
- 2016-10-28 KR KR1020227028040A patent/KR20220118559A/ko active Pending
- 2016-10-28 JP JP2018522126A patent/JP6833844B2/ja active Active
- 2016-10-28 MY MYPI2018701596A patent/MY201783A/en unknown
- 2016-10-28 MX MX2018005294A patent/MX2018005294A/es unknown
- 2016-10-28 BR BR122020022275-1A patent/BR122020022275B1/pt active IP Right Grant
- 2016-10-28 MA MA43131A patent/MA43131B1/fr unknown
- 2016-10-28 CR CR20210390A patent/CR20210390A/es unknown
- 2016-10-28 KR KR1020187015208A patent/KR102434308B1/ko active Active
- 2016-10-28 DK DK22150809.6T patent/DK4011887T3/da active
- 2016-10-28 HR HRP20201046TT patent/HRP20201046T1/hr unknown
- 2016-10-28 HU HUE16860883A patent/HUE054972T2/hu unknown
- 2016-10-28 CN CN202110099502.4A patent/CN113150016A/zh active Pending
- 2016-10-28 PH PH1/2018/500899A patent/PH12018500899B1/en unknown
-
2018
- 2018-04-16 IL IL258731A patent/IL258731B/en active IP Right Grant
- 2018-04-27 CL CL2018001134A patent/CL2018001134A1/es unknown
- 2018-05-02 CO CONC2018/0004750A patent/CO2018004750A2/es unknown
- 2018-05-28 EC ECIEPI201840250A patent/ECSP18040250A/es unknown
- 2018-05-29 ZA ZA2018/03556A patent/ZA201803556B/en unknown
- 2018-08-10 US US16/101,275 patent/US10851118B2/en not_active Expired - Fee Related
-
2019
- 2019-03-28 CL CL2019000819A patent/CL2019000819A1/es unknown
- 2019-03-28 CL CL2019000821A patent/CL2019000821A1/es unknown
- 2019-03-28 CL CL2019000820A patent/CL2019000820A1/es unknown
- 2019-10-28 ZA ZA2019/07092A patent/ZA201907092B/en unknown
- 2019-10-28 ZA ZA2019/07091A patent/ZA201907091B/en unknown
- 2019-10-28 ZA ZA2019/07093A patent/ZA201907093B/en unknown
-
2020
- 2020-03-23 US US16/827,503 patent/US10844080B2/en active Active
- 2020-08-21 CY CY20201100780T patent/CY1123557T1/el unknown
- 2020-11-12 US US17/096,500 patent/US20210061822A1/en not_active Abandoned
- 2020-12-10 AU AU2020286278A patent/AU2020286278B2/en not_active Ceased
-
2021
- 2021-02-02 JP JP2021014795A patent/JP7032583B2/ja not_active Expired - Fee Related
- 2021-03-15 IL IL281503A patent/IL281503B/en unknown
- 2021-11-18 IL IL288225A patent/IL288225A/en unknown
-
2022
- 2022-02-22 JP JP2022025334A patent/JP2022071010A/ja not_active Withdrawn
- 2022-05-31 AU AU2022203703A patent/AU2022203703A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018533582A5 (enExample) | ||
| IL292677A (en) | Compositions and methods for inhibiting arginase activity | |
| HRP20201046T1 (hr) | Sastavi i metode za inhibitivnu aktivnost arginase | |
| US11912786B2 (en) | Inhibitor of apoptosis protein (IAP) antagonists | |
| US10604526B2 (en) | Chemokine receptor modulators and uses thereof | |
| ES2821790T3 (es) | Moduladores de la vía de estrés integrada | |
| KR102781404B1 (ko) | 통합 스트레스 경로의 조정제 | |
| AU2016229136B2 (en) | DNA alkylating agents | |
| CN104119350B (zh) | 氨基喹唑啉类衍生物及其盐和使用方法 | |
| JP2010533206A5 (enExample) | ||
| JP2019519599A (ja) | 統合ストレス経路のモジュレーター | |
| TW201945356A (zh) | 趨化介素受體調節劑及其用途 | |
| EP3802544A1 (en) | Pyrazolo-pyrimidin-amino-cycloalkyl compounds and their therapeutic uses | |
| ES2941790T3 (es) | Copolímeros dibloque autoensamblados compuestos de PEGMEMA y segmentos poliméricos portadores de fármacos | |
| JP2006507308A5 (enExample) | ||
| US20220274964A1 (en) | 5-bromo-indirubins | |
| JP2019194194A (ja) | 癌を治療するためのｈｄａｃ８阻害剤 | |
| US9399639B2 (en) | Substituted azaindole compounds, salts, pharmaceutical compositions thereof and methods of use | |
| JP2019524852A5 (enExample) | ||
| JP2025525869A (ja) | フェロトーシスを誘導するための組成物および方法 | |
| JP2023501038A (ja) | 新規の治療的使用 | |
| JP2019536783A5 (enExample) | ||
| JP2014505052A (ja) | 癌の治療および予防用の新規なウレア | |
| CN106459011B (zh) | 作为抗肿瘤化合物的σ-2受体配体药物缀合物、其合成方法及其用途 | |
| JPWO2020257429A5 (enExample) |